BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28106288)

  • 1. Nuclear Inositide Signaling Via Phospholipase C.
    Ratti S; Mongiorgi S; Ramazzotti G; Follo MY; Mariani GA; Suh PG; McCubrey JA; Cocco L; Manzoli L
    J Cell Biochem; 2017 Aug; 118(8):1969-1978. PubMed ID: 28106288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of nuclear inositide signalling pathways during erythropoietin therapy in low-risk MDS patients.
    Follo MY; Mongiorgi S; Clissa C; Paolini S; Martinelli G; Martelli AM; Fioravanti G; Manzoli L; Finelli C; Cocco L
    Leukemia; 2012 Dec; 26(12):2474-82. PubMed ID: 22596089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic regulation of nuclear PI-PLCbeta1 signaling pathway in low-risk MDS patients during azacitidine treatment.
    Follo MY; Russo D; Finelli C; Mongiorgi S; Clissa C; Filì C; Colombi C; Gobbi M; Manzoli L; Piazzi M; Martelli AM; Cocco L
    Leukemia; 2012 May; 26(5):943-50. PubMed ID: 22033492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phospholipase C beta1 (PI-PLCbeta1)/Cyclin D3/protein kinase C (PKC) alpha signaling modulation during iron-induced oxidative stress in myelodysplastic syndromes (MDS).
    Cappellini A; Mongiorgi S; Finelli C; Fazio A; Ratti S; Marvi MV; Curti A; Salvestrini V; Pellagatti A; Billi AM; Suh PG; McCubrey JA; Boultwood J; Manzoli L; Cocco L; Follo MY
    FASEB J; 2020 Nov; 34(11):15400-15416. PubMed ID: 32959428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear PI-PLCβ1 and myelodysplastic syndromes: genetics and epigenetics.
    Follo MY; Mongiorgi S; Finelli C; Piazzi M; Faenza I; Ramazzotti G; Santi P; McCubrey JA; Martelli AM; Cocco L
    Curr Pharm Des; 2012; 18(13):1751-4. PubMed ID: 22352752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of nuclear PI-PLCbeta1 during cell differentiation.
    Cocco L; Manzoli L; Faenza I; Ramazzotti G; Yang YR; McCubrey JA; Suh PG; Follo MY
    Adv Biol Regul; 2016 Jan; 60():1-5. PubMed ID: 26525203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear phospholipase C β1 signaling, epigenetics and treatments in MDS.
    Follo MY; Marmiroli S; Faenza I; Fiume R; Ramazzotti G; Martelli AM; Gobbi P; McCubrey JA; Finelli C; Manzoli FA; Cocco L
    Adv Biol Regul; 2013 Jan; 53(1):2-7. PubMed ID: 23058275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphoinositide-phospholipase C beta1 mono-allelic deletion is associated with myelodysplastic syndromes evolution into acute myeloid leukemia.
    Follo MY; Finelli C; Clissa C; Mongiorgi S; Bosi C; Martinelli G; Baccarani M; Manzoli L; Martelli AM; Cocco L
    J Clin Oncol; 2009 Feb; 27(5):782-90. PubMed ID: 19114693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear PI-PLCβ1: an appraisal on targets and pathology.
    Follo MY; Faenza I; Piazzi M; Blalock WL; Manzoli L; McCubrey JA; Cocco L
    Adv Biol Regul; 2014 Jan; 54():2-11. PubMed ID: 24296032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for PLCβ1 in myotonic dystrophies type 1 and 2.
    Faenza I; Blalock W; Bavelloni A; Schoser B; Fiume R; Pacella S; Piazzi M; D'Angelo A; Cocco L
    FASEB J; 2012 Jul; 26(7):3042-8. PubMed ID: 22459146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective Activation of Nuclear PI-PLCbeta1 During Normal and Therapy-Related Differentiation.
    Mongiorgi S; Follo MY; Yang YR; Ratti S; Manzoli L; McCubrey JA; Billi AM; Suh PG; Cocco L
    Curr Pharm Des; 2016; 22(16):2345-8. PubMed ID: 26916022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-time PCR as a tool for quantitative analysis of PI-PLCbeta1 gene expression in myelodysplastic syndrome.
    Follo MY; Bosi C; Finelli C; Fiume R; Faenza I; Ramazzotti G; Gaboardi GC; Manzoli L; Cocco L
    Int J Mol Med; 2006 Aug; 18(2):267-71. PubMed ID: 16820933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS.
    Follo MY; Finelli C; Mongiorgi S; Clissa C; Bosi C; Testoni N; Chiarini F; Ramazzotti G; Baccarani M; Martelli AM; Manzoli L; Martinelli G; Cocco L
    Proc Natl Acad Sci U S A; 2009 Sep; 106(39):16811-6. PubMed ID: 19805378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear inositide signaling in myelodysplastic syndromes.
    Follo MY; Mongiorgi S; Finelli C; Clissa C; Ramazzotti G; Fiume R; Faenza I; Manzoli L; Martelli AM; Cocco L
    J Cell Biochem; 2010 Apr; 109(6):1065-71. PubMed ID: 20058233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear phospholipase C: involvement in signal transduction.
    Manzoli L; Martelli AM; Billi AM; Faenza I; Fiume R; Cocco L
    Prog Lipid Res; 2005 Jul; 44(4):185-206. PubMed ID: 15896848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An increased expression of PI-PLCβ1 is associated with myeloid differentiation and a longer response to azacitidine in myelodysplastic syndromes.
    Cocco L; Finelli C; Mongiorgi S; Clissa C; Russo D; Bosi C; Quaranta M; Malagola M; Parisi S; Stanzani M; Ramazzotti G; Mariani GA; Billi AM; Manzoli L; Follo MY
    J Leukoc Biol; 2015 Nov; 98(5):769-80. PubMed ID: 25977289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear translocation of PKC-α is associated with cell cycle arrest and erythroid differentiation in myelodysplastic syndromes (MDSs).
    Poli A; Ratti S; Finelli C; Mongiorgi S; Clissa C; Lonetti A; Cappellini A; Catozzi A; Barraco M; Suh PG; Manzoli L; McCubrey JA; Cocco L; Follo MY
    FASEB J; 2018 Feb; 32(2):681-692. PubMed ID: 28970249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear phospholipase C isoenzyme imbalance leads to pathologies in brain, hematologic, neuromuscular, and fertility disorders.
    Ratti S; Follo MY; Ramazzotti G; Faenza I; Fiume R; Suh PG; McCubrey JA; Manzoli L; Cocco L
    J Lipid Res; 2019 Feb; 60(2):312-317. PubMed ID: 30287524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiology and pathology of nuclear phospholipase C β1.
    Cocco L; Follo MY; Faenza I; Fiume R; Ramazzotti G; Weber G; Martelli AM; Manzoli FA
    Adv Enzyme Regul; 2011; 51(1):2-12. PubMed ID: 21035488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic induction of PI-PLCβ1 signaling by azacitidine and valproic acid in high-risk myelodysplastic syndromes.
    Follo MY; Finelli C; Mongiorgi S; Clissa C; Chiarini F; Ramazzotti G; Paolini S; Martinelli G; Martelli AM; Cocco L
    Leukemia; 2011 Feb; 25(2):271-80. PubMed ID: 21109771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.